Sanofi, CEMKA, Lifen and SFGM-TC join forces to provide a better understanding of the care pathway for French patients suffering from chronic graft-versus-host disease.
Sanofi, CEMKA, Lifen and SFGM-TC join forces to provide a better understanding of the care pathway for French patients suffering from chronic graft-versus-host disease.
Sanofi, CEMKA, Lifen and SFGM-TC join forces to provide a better understanding of the care pathway for French patients suffering from chronic graft-versus-host disease.
.png)
